Alpha Tau Medical Ltd. Warrant
Save
22.38M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, lung, and prostate cancers. The company was founded in 2015 and is headquartered in Jerusalem, Israel.

Similar securities

Based on sector and market capitalization

Report issue